Melatonin and cognitive deficits in bipolar disorder and mild cognitive impairment

Psychotherapy and Psychosomatics

Volumn 81, Issue 4, 2012, Pages 244-

  Anderson, George ^a  

^a CRC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; MELATONIN; NEUROLEPTIC AGENT; VALPROIC ACID;

ADJUVANT THERAPY; BIPOLAR DISORDER; BRAIN DISEASE; COGNITIVE DEFECT; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERAMMONEMIA; LETTER; LEUKOPENIA; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; OBESITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTOPENIA;

BIPOLAR DISORDER; FEMALE; HUMANS; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84862025060     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000335247     Document Type: Letter

References (10)

1. Osher Y, Dobron A, Belmaker RH, Bersudsky Y, Dwolatzky T: Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls. Psychother Psychosom 2011; 80: 298-303.
2. Monteleone P, Natale M, La Rocca A, Maj M: Decreased nocturnal secretion of melatonin in drug-free schizophrenics: no change after subchronic treatment with antipsychotics. Neuropsychobiology 1997; 36: 159-163. (Pubitemid 27472513)
3. Leboyer M, Etain B, Jamain S, Henry C, Bellivier F, Bourgeron T: Genetic exploration of the melatoninergic pathway in bipolar disorder. In preparation.
4. He H, Dong W, Huang F: Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease. Curr Neuropharmacol 2010; 8: 211-217.
5. Harvey AG: Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008; 165: 820-829.
6. Túnez I, Muñoz MC, Medina FJ, Salcedo M, Feijóo M, Montilla P: Comparison of melatonin, vitamin E and L-carnitine in the treatment of neuro- and hepatotoxicity induced by thioacetamide. Cell Biochem Funct 2007; 25: 119-127. (Pubitemid 46408644)
7. Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thamas RG, Schneider LS, Tariot PN: Chronic divalproex sodium use and brain atrophy in Alzheimer disease. Neurology 2011; 77: 1263-1271.
8. Warskulat U, Görg B, Bidmon HJ, Müller HW, Schliess F, Häussinger D: Ammonia induced heme oxygenase-1 expression in cultured rat astrocytes and rat brain in vivo. Glia 2002; 40: 324-336. (Pubitemid 36010739)
9. Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD: Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology 2007; 32: 284-288. (Pubitemid 46106935)
10. Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, Wong C, Thanos PK, Ma Y, Pradhan K: Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 2009; 17: 60-65. (Pubitemid 50310542)